An uncertain political environment down south coupled with international ambitions means Canadian-based Licensed Producers are still the best bet for international investors looking for exposure to marijuana stocks, says M Partners analyst Mason Brown. 

Yesterday, Canopy Growth Corp. (TSX:CGC) announced it would acquire German-based pharmaceutical distributor MedCann. 

“Germans need access to high-quality cannabis and Tweed’s products are proving to be up to the very strict standards set by the federal government,” said Medcann founder Dr. P. Debs. “Working together as one team will allow Canopy Growth through Tweed, Tweed Farms, and future production sites to supply the unmet demand that has been building over the past decade.”

Brown says that while the German marijuana market is still “miniscule”, the company is clearly moving toward a system similar to what Canada has. The analyst says he believes a mature German cannabis market could be worth $3.7-billion. 

International ambitions such as the ones demonstrated...